title: [Expression of galectin-3 in invasive prolactinomas].
abstract: OBJECTIVE
  To investigate the expression of galectin-3 (Gal-3) in prolactinomas.
  
  
  METHODS
  Expressions of Gal-3 were evaluated by immunohistochemistry using polyclonal antibody in 16 invasive prolactinomas and 16 prolactinomas.
  
  
  RESULTS
  Gal-3 was expressed both in invasive prolactinomas and noninvasive prolactinomas while significantly higher expression seen in the invasive prolactinomas (P < 0.05).
  
  
  CONCLUSIONS
  Gal-3 expression may be used as a useful indicator to determine the invasiveness and prognosis of prolactinomas.
authors.affiliation: Department of Neurosurgery, Affiliated Hospital of Hebei Medical College for Continuous Education, Baoding 071000, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Wang
authors.forename: Ming-dong
authors.initials: MD
authors.lastname: Wang
authors.forename: Wen-bin
authors.initials: WB
authors.lastname: Ma
authors.forename: Di
authors.initials: D
authors.lastname: Yang
authors.forename: Yan-Fang
authors.initials: YF
authors.lastname: Shi
authors.forename: Yan-guo
authors.initials: YG
authors.lastname: Kong
authors.forename: Shi-fang
authors.initials: SF
authors.lastname: Li
authors.forename: Zhi-hong
authors.initials: ZH
authors.lastname: Li
authors.forename: Ren-zhi
authors.initials: RZ
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D037502:Galectin 3 / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis; D015175:Prolactinoma / Q000378:metabolism* / Q000473:pathology
chemical_list: D037502:Galectin 3